Skip to main content

Point-of-Care Warfarin Monitoring in the ROCKET AF Trial.

Publication ,  Journal Article
Patel, MR; Hellkamp, AS; Fox, KAA; ROCKET AF Executive Committee and Investigators,
Published in: N Engl J Med
February 25, 2016

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

N Engl J Med

DOI

EISSN

1533-4406

Publication Date

February 25, 2016

Volume

374

Issue

8

Start / End Page

785 / 788

Location

United States

Related Subject Headings

  • Warfarin
  • Thiophenes
  • Morpholines
  • Male
  • Humans
  • General & Internal Medicine
  • Female
  • Atrial Fibrillation
  • Anticoagulants
  • 42 Health sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Patel, M. R., Hellkamp, A. S., Fox, K. A. A., & ROCKET AF Executive Committee and Investigators, . (2016). Point-of-Care Warfarin Monitoring in the ROCKET AF Trial. N Engl J Med, 374(8), 785–788. https://doi.org/10.1056/NEJMc1515842
Patel, Manesh R., Anne S. Hellkamp, Keith A. A. Fox, and Keith A. A. ROCKET AF Executive Committee and Investigators. “Point-of-Care Warfarin Monitoring in the ROCKET AF Trial.N Engl J Med 374, no. 8 (February 25, 2016): 785–88. https://doi.org/10.1056/NEJMc1515842.
Patel MR, Hellkamp AS, Fox KAA, ROCKET AF Executive Committee and Investigators. Point-of-Care Warfarin Monitoring in the ROCKET AF Trial. N Engl J Med. 2016 Feb 25;374(8):785–8.
Patel, Manesh R., et al. “Point-of-Care Warfarin Monitoring in the ROCKET AF Trial.N Engl J Med, vol. 374, no. 8, Feb. 2016, pp. 785–88. Pubmed, doi:10.1056/NEJMc1515842.
Patel MR, Hellkamp AS, Fox KAA, ROCKET AF Executive Committee and Investigators. Point-of-Care Warfarin Monitoring in the ROCKET AF Trial. N Engl J Med. 2016 Feb 25;374(8):785–788.

Published In

N Engl J Med

DOI

EISSN

1533-4406

Publication Date

February 25, 2016

Volume

374

Issue

8

Start / End Page

785 / 788

Location

United States

Related Subject Headings

  • Warfarin
  • Thiophenes
  • Morpholines
  • Male
  • Humans
  • General & Internal Medicine
  • Female
  • Atrial Fibrillation
  • Anticoagulants
  • 42 Health sciences